Peter Kurtzhals
Senior Vice President
Novo Nordisk A/S
pkur(at)novonordisk.com
Career
Dr. Peter Kurtzhals is Senior Vice President and Head of Diabetes Research at Novo Nordisk A/S.
Peter Kurtzhals joined Novo Nordisk in 1990. He has held positions as Principal Scientist in the Insulin Research group at Novo Nordisk, as a Visiting Scientist at the Joslin Diabetes Center, and Harvard Medical School in Boston, and as Head of Diabetes Biology at Novo Nordisk. He was appointed Vice President and Head of Discovery Biology in 2000 and Senior Vice President and member of Novo Nordisk’s Senior Management Board in 2001. Peter Kurtzhals has been the Scientific Coordinator for Novo Nordisk's insulin analogue projects, including insulin aspart and insulin detemir.
Prior to joining Novo Nordisk, Peter Kurtzhals worked as an Assistant Professor at The Danish University of Pharmaceutical Sciences, from where he holds MSc and PhD degrees.
Peter Kurtzhals is frequently sought as an invited speaker at international meetings and symposia.
Peter Kurtzhals is Chairman of The Committee on Research Policy, The Danish Association of the Pharmaceutical Industry and member of EFPIA’s Research Director Group. Peter Kurtzhals is furthermore a member of the board of The Danish University of Pharmaceutical Sciences and a member of the board of Steno Diabetes Center.